Publisher
Springer International Publishing
Reference46 articles.
1. Zane M, Agostini M, Enzo MV, et al. Circulating cell-free DNA, SLC5A8 and SLC26A4 hypermethylation, BRAF(V600E): a non-invasive tool panel for early detection of ThyCa. Biomed Pharmacother. 2013;67:723–30.
2. Chuang TC, Chuang AY, Poeta L, et al. Detectable BRAF mutation in serum DNA samples from patients with papillary thyroid carcinomas. Head Neck. 2010;32:229–34.
3. Kim BH, Kim IJ, Lee BJ, et al. Detection of plasma BRAF(V600E) mutation is associated with lung metastasis in papillary thyroid carcinomas. Yonsei Med J. 2015;56:634–40.
4. Pupilli C, Pinzani P, Salvianti F, et al. Circulating BRAFV600E in the diagnosis and follow-up of differentiated papillary thyroid carcinoma. J Clin Endocrinol Metab. 2013;98:3359–65.
5. Barzon L, Boscaro M, Pacenti M, et al. Evaluation of circulating thyroid-specific transcripts as markers of ThyCa relapse. Int J Cancer. 2004;110:914–20.